SCHEMBL5830982

SCHEMBL5830982

COC(=O)C1C[C@@H](O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)C[C@@H](O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
ATM Q13315 1/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BACE1 P56817 1/20 0.34
SLC6A3 Q01959 3/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
CYP2C19 P33261 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5830984 1.00 ALDH1A1 (0.36) ALDH1A1ATMHSD17B10CYP1A2CYP3A4
SCHEMBL20064242 0.99 ALDH1A1 (0.37) ALDH1A1ATMHSD17B10CYP1A2CYP3A4
SCHEMBL20495445 0.99 ALDH1A1 (0.37) ALDH1A1ATMHSD17B10CYP1A2CYP3A4
SCHEMBL21987398 0.91 ALDH1A1 (0.33) ALDH1A1ATMHSD17B10CYP1A2CYP3A4
SCHEMBL26964685 0.90 ALDH1A1 (0.38) ALDH1A1ATMHSD17B10CYP1A2CYP3A4
SCHEMBL5831941 0.87 BACE1 (0.36) CYP3A4HTTSMN1; SMN2BACE1
SCHEMBL5831935 0.87 BACE1 (0.36) CYP3A4HTTSMN1; SMN2BACE1
SCHEMBL5571506 0.87 HSD11B1 (0.37) ALDH1A1ATMHSD17B10CYP1A2HTT
SCHEMBL5571511 0.87 HSD11B1 (0.37) ALDH1A1ATMHSD17B10CYP1A2HTT
SCHEMBL5571508 0.87 HSD11B1 (0.37) ALDH1A1ATMHSD17B10CYP1A2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115740-B2 Pyrimido compounds having antiproliferative activity HOFFMANN-LA ROCHE INC. (US) 2006-10-03 US disclosed
US-20040204427-A1 Pyrimido compounds having antiproliferative activity CHEN YI (US) 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204427-A1 Pyrimido compounds having antiproliferative activity FGFR3, FGFR1, FGFR4 ALDH1A1 527/4885ATM 536/4885HSD17B10 3029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.